London Co. of Virginia Invests $170.02 Million in The Cooper Companies, Inc. $COO

London Co. of Virginia purchased a new position in The Cooper Companies, Inc. (NASDAQ:COO) in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 2,074,379 shares of the medical device company’s stock, valued at approximately $170,016,000. London Co. of Virginia owned 1.06% of Cooper Companies at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the stock. Captrust Financial Advisors lifted its stake in shares of Cooper Companies by 23.5% in the 4th quarter. Captrust Financial Advisors now owns 8,860 shares of the medical device company’s stock worth $726,000 after acquiring an additional 1,687 shares during the period. &PARTNERS lifted its stake in shares of Cooper Companies by 1.8% in the 4th quarter. &PARTNERS now owns 30,312 shares of the medical device company’s stock worth $2,484,000 after acquiring an additional 533 shares during the period. ExodusPoint Capital Management LP lifted its stake in shares of Cooper Companies by 886.9% in the 4th quarter. ExodusPoint Capital Management LP now owns 158,371 shares of the medical device company’s stock worth $12,980,000 after acquiring an additional 142,324 shares during the period. Blair William & Co. IL lifted its stake in shares of Cooper Companies by 53.6% in the 4th quarter. Blair William & Co. IL now owns 19,590 shares of the medical device company’s stock worth $1,606,000 after acquiring an additional 6,835 shares during the period. Finally, Graham Capital Management L.P. acquired a new stake in shares of Cooper Companies in the 4th quarter worth approximately $969,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Down 0.6%

COO stock opened at $67.35 on Wednesday. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The firm has a market cap of $13.14 billion, a PE ratio of 57.08, a P/E/G ratio of 1.77 and a beta of 0.87. The firm has a 50 day simple moving average of $64.68 and a 200 day simple moving average of $74.19. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analysts Set New Price Targets

COO has been the subject of a number of research analyst reports. Stifel Nicolaus reduced their price target on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, June 5th. Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. Wall Street Zen lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Saturday. Mizuho set a $85.00 target price on shares of Cooper Companies and gave the company an “outperform” rating in a research note on Thursday, June 4th. Finally, Needham & Company LLC cut their target price on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research note on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $81.31.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.